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A retrospective analysis of the microbiology
of diabetic foot infections at a Scottish
tertiary hospital
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Abstract
Background: This study represents the first Scottish retrospective analysis of the microbiology of diabetic foot
infections (DFIs). The aims were to compare the microbiological profile of DFIs treated at a Scottish tertiary
hospital to that in the literature, gather data regarding antimicrobial resistance and investigate potential
trends between the microbiological results and nature or site of the clinical sample taken and age or gender
of the patients.
Methods: A retrospective analysis of wound microbiology results was performed, data were obtained
from one multidisciplinary outpatient foot clinic during the 12 months of the year 2017. Seventy-three
patients and 200 microbiological investigations were included. In cases of soft tissue infection, the
deepest part of a cleansed and debrided wound was sampled. In cases of osteomyelitis a bone biopsy
was obtained. Factors influencing the pattern of microbial growth or prevalence of Staphylococcus
aureus were investigated.
Results: Of the 200 microbiological investigations, 62% were culture positive, of which 37.9% were
polymicrobial and 62.1% monomicrobial. Among the monomicrobial results (n = 77), most were Gram
positive isolates (96.1%) and the most frequently isolated bacteria was S. aureus (84.4%). No methicillin-
resistant S. aureus was reported. The prevalence of S. aureus in DFIs was associated with increasing
age (p = 0.021), but no evidence of association with gender, anatomical sample site or sample material
was found.
Conclusion: The microbiological profile of DFIs in Scotland resembles that reported elsewhere in the UK. In
this context, Gram positive organisms, primarily S. aureus, are most frequently isolated from DFIs. The S.
aureus isolates identified were largely susceptible to antibiotic therapy. An association between increasing
patient age and the prevalence of S. aureus in DFIs was observed.
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Background
Diabetes mellitus, herein diabetes, is the most common
metabolic disease in the world. In 2014 there were an es-
timated 422 million adults living with diabetes, and the
global prevalence continues to increase, with a projected
592 million people living with the condition by 2035 [1,
2]. Around one third of patients with diabetes will de-
velop a diabetic foot ulcer (DFU) and approximately half
of these will become infected [3]. DFUs develop second-
ary to a variety of factors, including peripheral neur-
opathy and peripheral arterial disease [4]. Diabetes in
Scotland represents a significant burden, with nearly
300,000 people registered as having the condition in
2017 [5]. Many of these individuals (44.2%) have had
diabetes for more than 20 years [5], a significant risk fac-
tor for the development of a DFU [6].
Infected DFUs are known as diabetic foot infections
(DFIs) and carry a high burden morbidity and increased
risk of mortality [3]. The microorganisms most com-
monly isolated from DFIs are aerobic Gram positive bac-
teria, predominantly Staphylococci [7, 8]. The prevalence
of methicillin resistant Staphylococcus aureus (MRSA) in
DFIs is considered to be 15–30% [8, 9]. Other bacterial
genera commonly found in DFIs include Streptococci,
Enterococci, Enterobacteriaceae, and Pseudomonas [3].
These infections are often polymicrobial and under-
standing the melange of species present can help inform
clinical practice. Treatment for DFIs consists of wound
care and antibiotics. The chronic and recalcitrant nature
of these infections typically requires the administration
of long courses of antibiotics, which may contribute to
antimicrobial resistance. The efficacy of haematogen-
ously distributed antibiotics may be further hampered by
peripheral arterial disease [10].
An understanding of the microbiology of DFIs is im-
portant to inform clinical practice, offer insight into local
microbiological trends and direct novel therapeutic strat-
egies. To date, there has been just one small prospective
study of the microbiology of DFIs in Scotland [11]. To
supplement this, we therefore undertook the first Scottish
retrospective analysis of the microbiology of DFIs. All DFI
patients treated at an outpatient clinic at the Queen Eliza-
beth University Hospital (QEUH) in Glasgow during the
12months of 2017 were included. The objectives were to
compare the local microbiological profile to that in the lit-
erature, gather data regarding antimicrobial resistance and
investigate potential relationships between the microbio-
logical results and nature or site of the clinical sample
taken and age or gender of the patients.
Methods
This retrospective cohort study was undertaken in the
multidisciplinary diabetic foot service at the tertiary Queen
Elizabeth University Hospital in Glasgow, Scotland. The
results of all microbiological investigations ordered by one
multidisciplinary outpatient foot clinic during the 12
months of the year 2017 were retrieved by members of the
direct care team. The age (years) and gender of each patient
were recorded. Further information about the diabetes type
of these patients could not readily be obtained due to the
division of patient data between discrete electronic plat-
forms. Microbiological investigations were undertaken,
prior to the administration of antibiotics. Wound sampling
was performed according to the National Institute for
Health and Clinical Excellence guidelines for diabetic foot
problems 1.6.1 [12]. All samples were taken from the base
of a cleansed and debrided wound. In cases of soft tissue in-
fection, a deep wound swab was taken from the debrided
ulcer base. Bone biopsies were obtained in cases of sus-
pected osteomyelitis. For all investigations, care was taken
to prevent contamination with skin flora and provide clinic-
ally relevant results to inform patient care. All microbio-
logical investigations were performed according to the UK
Standards for Microbiology Investigations and local micro-
biological guidelines. Deep tissue swabs were placed on
Amies transport medium with charcoal and sent to the
Queen Elizabeth University Hospital Microbiology Depart-
ment. Bone biopsies were placed in a sterile universal con-
tainer. All samples were cultured for aerobic and anaerobic
microorganisms, pure cultures were obtained and subjected
to antibiotic sensitivity testing. The presence of coagulase
negative Staphylococci in deep tissue swabs is routinely pre-
sumed to indocate skin flora and is not reported as signifi-
cant growth. The following data were recorded for each
result: investigation site (broadly divided into foot, toe or
ankle), material sampled (bone biopsy or deep tissue swab)
and general bacterial growth (no significant growth, mono-
microbial or polymicrobial). For monomicrobial plates, the
species identified were recorded, alongside any available
antimicrobial sensitivity data. All data were anonymised be-
fore secure transmission from NHS Greater Glasgow &
Clyde to the University of Edinburgh. This study was per-
formed as a quality improvement study and Caldicott
Guardian approved by NHS Greater Glasgow and Clyde.
Statistical analyses were performed using RStudio (ver-
sion 1.1456) and Microsoft Excel. In R, the “lme4” and
“lmerTest” packages were utilised [13, 14]. Four general-
ised linear mixed-effects model were run, taking into ac-
count the random effects of patients, to analyse the
statistical significance of each parameter recorded in
turn (the four independent variables: age, gender, inves-
tigation site and material sampled) in influencing the
prevalence of S. aureus. The dependent variable in our
models was the binomial response of whether an investi-
gation signalled a S. aureus infection (‘yes’ vs. ‘no’);
therefore, our models assumed a binomial distribution.
We report our model results in terms of the ‘log odds’
that a given clinical sample is infected, log(p/(1-p)),
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where p equals the probability that a sample is infected.
Therefore, p/(1-p) represents the odds of infection. For
example, if the probability of being infected is 0.8, then
the odds of being infected equals four (0.8/0.2). The
‘Diagnostics for HierArchical Regression Models’
(DHARMa) package was used to check the residuals for
the mixed effects model [15]. Microsoft Excel was used
to perform descriptive statistics on age, clinical micro-
biology and antimicrobial resistance.
Results
Study population
Seventy-three patients from one multi-disciplinary
diabetic foot outpatient clinic had one or more
microbiological investigations during 2017 and were
therefore included in this retrospective study. In cases
of soft tissue infection, deep tissue swabs were taken
from the cleansed and debrided ulcer base. Bone bi-
opsies were obtained in suspected cases of osteomye-
litis. A total of 201 microbiological investigations
were performed, however microbiological data for one
monomicrobial deep tissue swab result were missing
and this result was excluded; therefore, 200 microbio-
locial results were included in this analysis. The study
population comprised 56 males and 17 females. The
age of the patients ranged from 28 to 94, with an
average age (± standard deviation) of 63.8 ± 12.8 years
(Fig. 1).
The effect of gender, swab site and sample material on
the nature of the swab result
Of the 200 microbiological investigations, 62% were cul-
ture positive, 37.9% of which were polymicrobial and
62.1% were monomicrobial. The distribution of the 200
results by gender, anatomical sample site and material
sampled is shown in Table 1. About a third (38.1%
male; 37.5% female) of investigations did not yield
significant growth (i.e. these samples were sterile or
represented presumed skin flora and were not re-
ported by the Microbiology Department as signifi-
cant). Among those infected, the majority had
monomicrobial infections. A high proportion of
monomicrobial results was also observed among clin-
ical samples taken from foot (42.4%) or toe (36.2%)
infections and from deep tissue (39.3%) swabs. Few
clinical samples were obtained from the ankle (n = 3)
and there were few bone biopsy (n = 9) results avail-
able. A Chi-Square test could not be performed with
these data because of violation of the assumption of
independence as some patients provided multiple
sample results.
The microbiological profile of diabetic foot infection
The mean number of microbiological results per pa-
tient was 2.74 with a range of one to nine results and
a mode of one. In some cases, the results of patients
who had had multiple investigations were identical.
However, clinical staff at QEUH advised that micro-
biological investigations are only routinely taken at
the start of an infectious episode, with patients then
being treated until clinical resolution of infection.
Additional investigations in the same patient therefore
likely reflect a new episode of infection. Therefore, all
results were included in the analyses.
Among the results, 124 were positive for microbial
growth, representing 1.70 positive cultures per patient.
Fig. 1 The age distribution of the diabetic foot patients included in this study (n = 73)
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An exact mean number of isolates per patients could
not be calculated given the polymicrobial nature of some
results. The microorganisms isolated are detailed in
Table 2.
Excluding fungal, mixed and samples without
significant growth, there were 77 monomicrobial re-
sults, of which 96.1% were Gram positive bacterial
species and 3.9% were Gram negative. On a per pa-
tient basis (n = 73), only 4.1% of individuals ever grew
a Gram negative species, and 43 patients tested posi-
tive on at least one occasion for a Gram positive
bacterium.
The prevalence of S. aureus in diabetic foot infections was
influenced by age but not gender, anatomical sample site
or sample material
Staphylococcus aureus was found in 32.5% of all results
(n = 200) and accounted for 84.4% of the 77 monomi-
crobial results. We investigated whether the preva-
lence of S. aureus was related to gender, anatomical
sample site or sample material using separate general-
ised linear models with mixed effects for each variable
(Table 3). We found that the prevalence of S. aureus
was not influenced by gender (p = 0.249), anatomical
site (p = 0.202) or sample material (p = 0.556). A
fourth generalised linear mixed-effects model indi-
cated that the prevalence of S. aureus increased with
age (p = 0.0211). The significance of this effect per-
sisted following exclusion of the three youngest pa-
tients (potential outliers; aged 28, 29 and 36; p =
0.0451). We found that the mean change in log odds
of being infected with S. aureus increases by 0.0372 ±
0.0161 annually (equivalently, each year, the odds of
infection increase multiplicatively by exp.(0.0372)),
with an intercept of − 3.24. For example, at age 40
the predicted probability (i.e., out of 1) of having a S.
aureus positive DFI is 0.15. Once a patient reaches
age 60, this increases to 0.27. Finally, by age 80 the
predicted probability reaches 0.43. Thus, with increas-
ing age the probability of having a S. aureus positive
diabetic foot infection becomes more likely. Analyses
with DHARMa indicated that our data met the
assumptions of our model. To visualise this effect, we
calculated the proportion of S. aureus positive results
per patient, which ranged from 0 (if all swabs were
Table 1 The relationship between gender, sample site and sample type and the pattern of microbial growth observed
Pattern of microbial growth Total
n
(100%)
Monomicrobial
n (%)
Polymicrobial
n (%)
No significant growth
n (%)
All clinical samples 77 (38.5%) 47 (23.5%) 76 (38.0%) 200
Male 62 (36.9%) 42 (25.0%) 64 (38.1%) 168
Female 15 (46.9%) 5 (15.6%) 12 (37.5%) 32
Ankle 0 (0.0%) 0 (0.0%) 3 (100%) 3
Foot 39 (42.4%) 22 (23.9%) 31 (33.7%) 92
Toe 38 (36.2%) 25 (23.8%) 42 (40.0%) 105
Bone biopsy 2 (22.2%) 6 (66.7%) 1 (11.1%) 9
Deep tissue swab 75 (39.3%) 41 (21.5%) 75 (39.3%) 191
Table 2 The microorganisms reported from diabetic foot
wound cultures (n = 200)
Number of microbiological
results
Gram positive Staphylococcus aureus 65
Staphylococcus epidermidis 1
Staphylococcus
lugdenensis
2
Group B Streptococcus 2
Group C Streptococcus 1
Group F Streptococcus 1
Group G Streptococcus 1
Streptococcus constellatus 1
Total Gram positive 74
Gram negative Enterobacter hormaechei 1
Escherichia coli 1
Pseudomonas aeruginosa 1
Total Gram negative 3
Total monomicrobial
swabs
77
Yeasts 1
Mixed aerobic 40
Mixed anaerobic 6
Total positive swabs 124
No significant growth 76
Total 200
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negative) to 1 (if all results were positive), and plotted
these data against the age for each individual (Fig. 2).
Antimicrobial resistance of S. aureus
Finally, we examined the available antimicrobial sensitiv-
ity data. For some patients, antimicrobial resistance was
investigated at multiple clinic visits. A total of 62 micro-
biological results from 38 S. aureus positive patients
were tested for flucloxacillin resistance, with 95.2% of S.
aureus isolates found to be sensitive. Clarithromycin
sensitivity was investigated for 62 S. aureus isolates ob-
tained from 38 patients, two of which were not tested
for flucloxacillin resistance; of these 72.6% of S. aureus
isolates were found to be sensitive. A small number of
other S. aureus antibiotic sensitivity investigations were
requested, with 95% sensitivity recorded against doxy-
cycline (n = 20) and 100% sensitivity to penicillin (n = 8),
clindamycin (n = 4) and vancomycin (n = 1). Notably, no
MRSA was detected in this study.
Discussion
This study represents the first retrospective analysis of
the microbiology of DFIs undertaken in Scotland. The
aim was to investigate whether the microbiological pro-
file of diabetic foot infections at a Scottish hospital was
comparable to previously published reports. The litera-
ture suggests that in the UK Staphylococci, particularly
S. aureus, are most commonly isolated from DFIs [16–
19], and the findings of this study support this. A previ-
ous prospective culture-based microbiological analysis of
20 Scottish DFI samples also identified S. aureus as the
most common microorganism, present in 40% of sam-
ples [11]. Although widely associated with DFIs,
Staphylococci often exist as commensal organisms, par-
ticularly in the nose and throat, and the prevalence of S.
aureus carriage is thought to be around 30% [20]. This is
supported by UK data, including a community-based
study which showed a S. aureus carriage rate of 28% [21]
and a prevalence of 41% among Royal Marine recruits
[22]. Staphylococci often colonise the skin [23, 24], and,
despite following guidelines for the investigation of
wound microbiology, we therefore cannot exclude the
possibility that some Staphylococcal cultures represent
skin commensals. For this reason coagulase-negative
Staphylococci are locally not routinely reported for deep
tissue swabs. Other major pathogens associated with
DFIs include Enterococci, Streptococci, Escherichia coli
and Pseudomonas aeruginosa [25]. However, these path-
ogens either occurred at a relatively low frequency or
were absent from our data. It has been reported that
Gram positive organisms are often more frequently iso-
lated from DFIs in Western nations, with Gram
Table 3 The effect of gender, anatomical swab site and sample
material on the prevalence of S. aureus among DFI patients
The prevalence of S. aureus in:
All results
(n = 200)
Monomicrobial
results (n = 77)
P value
32.5%
(n = 200)
84.4%
(n = 65)
-
Male 30.3%
(n = 168)
82.3%
(n = 62)
-
Female 43.8%
(n = 32)
93.33%
(n = 15)
(p = 0.249)
Ankle 0%
(n = 3)
0%
(n = 3)
-
Foot 38%
(n = 92)
78.9%
(n = 38)
-
Toe 28.5%
(n = 105)
89.7%
(n = 39)
(p = 0.202)
Bone biospy 22.2%
(n = 9)
100%
(n = 2)
-
Deep tissue swab 33.3%
(n = 191)
84%
(n = 75)
(p = 0.556)
Fig. 2 The effect of age on the prevalence of S. aureus among diabetic foot infections (n = 73)
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negatives more frequently isolated from warmer cli-
mates, including Asia and Africa. The reasons for this
remain unclear but could reflect a variety of environ-
mental, clinical or personal factors [26]. The frequency
of samples with no significant growth (38%) is broadly
comparable with that found in similar studies in the UK
[16, 19], and similar to that reported for the only other
Scottish analysis of the microbiology of DFIs (45%) per-
formed at the same hospital [11].
Given the potential breadth of associated factors and
limited sample size, it was not surprising that our de-
scriptive analysis of gender and anatomical sample site
did not reveal any clear association with the broad pat-
tern of microbiological growth observed. Although ana-
lysis of these data was limited by violation of an
assumption of the Chi-Square test, the difference be-
tween the microbiological patterns reported from bone
biopsies and deep tissue swabs was intriguing, but lim-
ited by the sample size. A higher frequency of polymi-
crobial results from bone samples could suggest that
these patients had deeper and potentially more complex
and chronic infections. More broadly, there are conflict-
ing reports of the concordance of bone and tissue sam-
ples [27, 28].
Young age and male gender are among a range of fac-
tors sometimes considered to increase the carriage of S.
aureus carriage in the community, although mixed re-
sults have been observed [20, 29]. While these factors
may affect carriage rates, this study found no evidence
that gender is a factor that contributes to the chance of
having a S. aureus positive DFI. There was also no evi-
dence to suggest that sample site or material were asso-
ciated with a higher rate of S. aureus infection. This
study therefore suggests that the rate of S. aureus posi-
tive DFIs may be independent of these factors, however
these findings are somewhat limited by the statistical
power. In general, the prevalence of commensal S. aur-
eus colonisation is considered to decline with increasing
age, including among hospital patients [20, 29]. How-
ever, this study found that the prevalence of S. aureus in
DFIs was in fact associated with increasing patient age.
The reasons for this are unclear, but it may reflect sam-
ple size or underlying temporal trends in the clinical
state of these patients.
Antimicrobial resistance is a common finding in DFIs,
with meta-analyses estimating the global prevalence of
methicillin-resistant S. aureus in DFIs to be 15–30% [8,
9]. Previous studies in the UK have reported higher
rates, ranging from 19.9 to 57.9% [16–19]. Reassuringly
this analysis did not report the isolation of any MRSA
and, where investigated, a high degree of sensitivity to
flucloxacillin was observed. However, 27.4% resistance to
clarithromycin was detected, although this is comparable
with previous Scottish data [30]. The absence of notable
antimicrobial resistance from these data could suggest
that current hospital infection control and MRSA
screening policies are effective. However, decreases in
antimicrobial resistance have also previously been asso-
ciated with changes in the dominance of the circulating
bacterial strain [31].
This study was hindered by an inability to access more
relevant clinical data. This represents a wider limitation
of clinical research that encounters the use of discrete
databases and systems for different clinical utilities. A
further limitation is the potential for intrinsic bias be-
cause of individual patients contributing multiple results,
although these most likely represented different infec-
tious episodes from the same foot ulcer. We considered
addressing this by removing duplicate results from indi-
vidual patients but deemed that the greatest clinical rele-
vance was provided by the data as presented. Provision
of multiple results may therefore have also introduced a
degree of bias into the antimicrobial resistance data as,
for genetic or behavioural reasons, some patients may be
more prone to infection with certain bacterial species.
Knowledge of the microbiology of diabetic foot infec-
tions is important in helping monitor the presence of
antimicrobial resistance among this at-risk population
and provides evidence to guide the targeting of novel
anti-infectives.
Conclusion
In summary, this retrospective analysis has increased the
understanding of the microbiology of DFIs in Scotland,
provided reassuring data regarding antimicrobial resist-
ance and suggests that the prevalence of S. aureus in
DFIs may be associated with increasing patient age.
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